| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 190 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 190 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 190 |
| 3 | FLUOROURACIL | 131 |
| 4 | FLUOROURACIL CREAM, 0.5% | 131 |
| 5 | METHOTREXATE SODIUM | 118 |
| 6 | PACLITAXEL | 95 |
| 7 | METHOTREXATE | 94 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 94 |
| 9 | ETOPOSIDE | 91 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOXANTRONE HYDROCHLORIDE | 88 | 0.0140 |
| 1 | ARSENIC TRIOXIDE | 29 | 0.0126 |
| 2 | BABY PETROLEUM JELLY | 1 | 0.0097 |
| 3 | WHITE PETROLATUM JELLY | 1 | 0.0096 |
| 4 | UNDECYLENIC ACID | 1 | 0.0072 |
| 5 | CEFTAZIDIME, AVIBACTAM | 1 | 0.0059 |
| 6 | MITOMYCIN | 20 | 0.0055 |
| 7 | TRETINOIN | 38 | 0.0046 |
| 8 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 9 | TRIMIPRAMINE | 4 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 251 |
| 1 | Alkylating Drug [EPC] | 223 |
| 2 | Platinum-based Drug [EPC] | 138 |
| 3 | Microtubule Inhibitor [EPC] | 127 |
| 4 | Corticosteroid [EPC] | 120 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 97 |
| 6 | Topoisomerase Inhibitor [EPC] | 91 |
| 7 | Aromatase Inhibitor [EPC] | 43 |
| 8 | Retinoid [EPC] | 38 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 7 | 0.0019 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 3 | Topoisomerase Inhibitor [EPC] | 91 | 0.0012 |
| 4 | Monobactam Antibacterial [EPC] | 3 | 0.0011 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 251 | 0.0009 |
| 6 | Alkylating Drug [EPC] | 223 | 0.0009 |
| 7 | Microtubule Inhibitor [EPC] | 127 | 0.0008 |
| 8 | Platinum-based Drug [EPC] | 138 | 0.0005 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 9 | 0.0004 |